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Introduction: 22q11.2 deletion syndrome (22q11DS) represents one of the largest known genetic risk factors for
psychosis, yet the neurobiologicalmechanisms underlying symptomdevelopment are not well understood. Here
we conducted a cross-sectional study of 22q11DS to decompose cortical volume into its constituent parts, cortical
thickness (CT) and surface area (SA), which are believed to have distinct neurodevelopmental origins.
Methods:High-resolution T1-weighted scanswere collected on 65participants (31 22q11DS, 34demographically
comparable typically developing controls, 10–25 years old). Measures of cortical volume, CT, and SA were
extracted from regions of interest using the FreeSurfer image analysis suite. Group differences and age-related
trajectories in these structures, as well as their association with psychotic symptomatology, were assessed.
Results: Relative to controls, 22q11DS participants showed bilateral volumetric reductions in the inferior
temporal cortex, fusiform gyrus, anterior cingulate, superior parietal cortex, and cuneus, which were driven by
decreased SA in these regions. 22q11DS participants also had increased volumes, driven by increased CT, in
bilateral insula regions. 22q11DS youth had increased CT in frontal regions, particularly middle frontal and
medial orbitofrontal cortices. A pattern of age-associated cortical thinning was observed in typically developing
controls in brain regions associatedwith visual and sensory information-processing (i.e., left pericalcarine cortex
and fusiform gyrus, right lingual and postcentral cortices). However, this relationship was disrupted in 22q11DS
participants. Finally, correlational analyses revealed that increased CT in right medial orbitofrontal cortex was
associated with increased positive symptom severity in 22q11DS.
Conclusion: Differential disruptions of CT and SA in distinct cortical regions in 22q11DS may indicate
abnormalities in distinct developmental neural processes. Further, neuroanatomic abnormalities in medial
frontal brain structures disproportionately affected in idiopathic schizophrenia were associated with psychotic
symptom severity in 22q11DS youth, suggesting that disrupted biological processes in these cortical regions
may underlie development of psychotic symptoms, both in 22q11DS and in the broader population.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. NV, copynumber variation; CT,
iew for Prodromal Syndromes;
ovariance.
ioral Sciences, Box 956968, 300
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. Open access under CC BY license. 1. Introduction
Recent evidence regarding the genetic architecture of schizophrenia
suggests that rare genetic mutations, known as copy number variations
(CNVs), may play a larger role in the disorder's etiology than was
previously believed. One of the best-known CNVs associated with
schizophrenia is the 22q11.2 microdeletion syndrome (22q11DS).
Individuals with 22q11DS have substantially elevated rates of psychotic
illness, as high as 32% (Gothelf et al., 2007a), making it one of the
largest known risk factors for developing schizophrenia. 22q11.2
deletions account for about 1–2% of schizophrenia cases in the general
population (Bassett et al., 2010). Moreover, the core clinical phenotype
in schizophrenia patients with 22q11DS does not differ from
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Murphy et al., 1999). This syndrome therefore represents an excellent
model for investigating how a known genetic mutation may lead to
structural brain dysfunction, which in turn may relate to expression of
psychotic symptoms.
Meta-analyses of volumetric and voxel-based structural magnetic
resonance imaging studies of patients with idiopathic schizophrenia
have found consistent volumetric reductions in frontal (Fornito et al.,
2009; Hulshoff Pol and Kahn, 2008; Shepherd et al., 2012), temporal
(Honea et al., 2005; Hulshoff Pol and Kahn, 2008; Shepherd et al.,
2012), and medial temporal regions (Glahn et al., 2008), along with
the insula (Ellison-Wright et al., 2008; Glahn et al., 2008) and anterior
cingulate (Ellison-Wright et al., 2008; Glahn et al., 2008; Shepherd
et al., 2012). A recent study used surface-based methodology to
distinguish between cortical thinning and reduced cortical surface area
in a large sample of patients with schizophrenia, revealing that
volumetric reductions in these regions are primarily driven by reduction
in cortical thickness (CT), although reduced surface area (SA) was also
present in more circumscribed regions (Rimol et al., 2012).
There is some evidence that neuroanatomic regions typically
disrupted in idiopathic schizophrenia are also linked to psychotic
symptomatology in 22q11DS. Adults with 22q11DS and a schizophrenia
diagnosis have reduced frontal and superior temporal gyrus volumes, in
comparison to those with 22q11DS without a schizophrenia diagnosis
(Chow et al., 2002, 2011). In 22q11DS youth, volumetric reductions in
the bilateral cingulate gyrus (Dufour et al., 2008) and reduced temporal
gray matter have been associated with psychotic symptoms and severity
of thought problems (e.g., hearing things, having strange beliefs,
displaying odd behaviors), as measured by the Child Behavior Checklist
(Bearden et al., 2004), respectively. Also, decreases in superior temporal
gyrus volume predicted positive symptoms at a 3-year follow-up in
adolescents with 22q11DS (Kates et al., 2011a). Collectively, these
ﬁndings suggest that neuroanatomic alterations in fronto-temporal
brain regionsmayunderlie psychotic symptomdevelopment in 22q11DS.
However, no studies have yet investigated the independent
contributions of CT and SA to volumetric differences in 22q11DS. Recent
evidence suggests that these indices may be driven by different genetic
and neurobiological mechanisms. Two studies found that both indices
are heritable, yet they are not genetically correlated with each other,
indicating that measures of cortical volume combine at least two
distinct sources of genetic effects (Winkler et al., 2010). SA and CT
are also believed to arise from different progenitor cells, which create
glial cells and neurons at distinct points in corticogenesis, resulting
in SA ultimately reﬂecting the number of cortical columns and CT
representing numbers of neurons within the columns (Pontious et al.,
2008; Rakic, 1988). Thus, identifying differential contributions of these
sub-components of cortical volume in 22q11DS may help us better
understand abnormal developmental processes that occur during
corticogenesis in distinct brain regions in this syndrome.
This is a cross-sectional study examining alterations in cortical
volume, thickness, and SA in individuals with 22q11DS as compared
to demographically comparable controls. Based on previous ﬁndings,
we hypothesized that those with 22q11DS would have increased
volume in the insula (Simon et al., 2005), with concomitant volumetric
reductions in parieto-occipital (Bearden et al., 2007; Gothelf et al.,
2007b; Kates et al., 2001), temporal (Campbell et al., 2006; Chow et al.,
2002; Eliez et al., 2001), orbitofrontal (Kates et al., 2011b), and anterior
cingulate cortices (Dufour et al., 2008). Secondly, we wished to
investigate whether there was an altered age-associated trajectory of
structural changes in these brain regions in 22q11DS, given the
important role of adolescent neurodevelopmental changes in the onset
of psychosis (Paus et al., 2008). We hypothesized that the typical
adolescent developmental trajectory of cortical thinningwith increasing
age (Fjell et al., 2009; Tamnes et al., 2010) would be exaggerated in
those with 22q11DS, considered that increased cortical thinning has
been shown in idiopathic schizophrenia (Cobia et al., 2012) andindividuals who go on to develop psychosis (Jung et al., 2011; Sun
et al., 2009). Finally, we investigated whether neuroanatomic variation
in neuroanatomic regions, as indexed by CT and SA, accounts for
variability in positive symptoms in 22q11DS patients.
2. Methods
2.1. Participants
The total sample consisted of 65 participants (10–25 years old, 31
22q11DS and 34 controls), recruited from an ongoing longitudinal
study at the University of California, Los Angeles (UCLA). 22q11DS
participants all had a molecularly conﬁrmed diagnosis of 22q11.2
deletion syndrome. Exclusion criteria for all study participants
were: neurological or medical condition disorder that might affect
performance, insufﬁcient ﬂuency in English, and/or substance or alcohol
abuse and/or dependencewithin the past 6months. Controls additionally
must notmeet criteria for anymajormental disorder, with the exception
of attention deﬁcit-hyperactivity disorder (ADHD) or past episode of
depression, based on information gathered during administration of the
Structured Clinical Interview for DSM-IV Axis I Disorders (First et al.,
1997).
After study procedures had been fully explained, and participants
under the age of 18 years provided written assent, while their parent
or guardian completed written consent. The UCLA Institutional Review
Board (IRB) approved all study procedures and informed consent
documents.
2.2. Structured Interview for Prodromal Syndromes
A master's-level trained clinician assessed all participants on the
positive, negative, disorganized, and general symptom scales from the
Structured Interview for Prodromal Syndromes (SIPS; McGlashan,
2001). Symptoms on these scales are rated from 0 to 6, with zero
representing an absence of symptoms and six referring to an extremely
severe level of symptoms. All raters demonstrated good to excellent
inter-reliability for symptom ratings, with intra-class correlation
coefﬁcients (ICC's) ranging from 0.85 to 1.00. For the purposes of this
study, SIPS positive symptom total score was used as a dimensional
measure of psychotic symptoms (i.e., unusual thought content,
suspiciousness, grandiose ideas, perceptual abnormalities, and/or
disorganization communication). This measure encompasses a range
of symptom severity, including sub-threshold (prodromal) and fully
psychotic symptoms. Use of a dimensional measure that captures sub-
threshold psychotic symptoms (i.e., the SIPS) is important, given that
our age range falls within an “at-risk” developmental period.
2.3. MRI acquisition
All scanning were carried out on a Siemens 3 T “Tim Trio” MRI
scanner at the BrainMappingCenter atUCLA (22q11DS=17, controls=
17) or at the Center for Cognitive Neuroscience (22q11DS = 14,
controls= 17). Measures of brain structure were obtained with high-
resolution structural MRI. Each scan began with a 10-min acquisition
of standard images used for determining regional anatomy, including
a sagittal localizer image (TR/TE = 500/33 ms, 192 × 256 matrix), a
high-resolution T2-weighted axial image (TR/TE= 5000/33ms, 128 ×
128 matrix, FOV= 200 × 200mm), and a sagittal 1 mm3 T1-weighted
image (MPRAGE, TR/TE = 2300/2.91 ms, ﬂip angle = 9°; slice
thickness=1.20mm, 240×256 acquisition matrix).
2.4. MRI analysis
The FreeSurfer image analysis suite (version 5.0, http://surfer.nmr.
mgh.harvard.edu) surface-based processing pipelinewas used to derive
measures of volume, CT, and SA. FreeSurfer is a well-validated
407M. Jalbrzikowski et al. / NeuroImage: Clinical 3 (2013) 405–415processing protocol that has been previously described in detail (Dale
et al., 1999; Fischl et al., 1999). In short, the following steps were
taken in the processing stream: motion correction, transformation of
images to standard Talairach space, intensity normalization, removal of
non-brain tissue, segmentation of white matter and subcortical
structures, andﬁnal segmentation of cortical surfaces. Final segmentation
is based on both a subject-independent probabilistic atlas and subject-
speciﬁc measured values. Raters (MJ, AP, RJ) blind to diagnosis visually
inspected the scans at several points along the processing pipeline
and any errors were manually edited. Details regarding the
manual editing procedures can be found in the Supplementary text.
Using an automated computer algorithm, CT estimates were derived
by taking the distance between the gray–white matter border and
the pial surface at each vertex (Fischl and Dale, 2000). As in prior
publications (Bhojraj et al., 2011; Gutierrez-Galve et al., 2010; Meda
et al., 2012; Venkatasubramanian et al., 2012), surface area was
calculated by taking the sum of the area of the vertices in each
parcellation. Volume was then calculated as the product of the SA and
CT for each region.
We extracted values based on the Desikan FreeSurfer atlas (Desikan
et al., 2006). For two of the regions of interest, themiddle frontal cortexFig. 1. Neuroanatomic regions of interest examined in 22q11DS vs. typically dand anterior cingulate, the Desikan atlas (Desikan et al., 2006)
separately calculates caudal and rostral regions. Prior to extracting the
data, we used the merge label function in FreeSurfer to combine the
caudal and rostral labels for each region (i.e., caudal and rostral anterior
cingulate labels were merged together to make an anterior cingulate
label, caudal and rostral middle frontal labels were merged together to
make amiddle frontal cortex label). Additionally, we used this approach
to combine the pars orbitalis, pars triangularis, and pars opercularis to
create the inferior frontal cortex ROI. Thenwe extracted cortical volume,
SA, and CT from these regions, resulting in a total of 30 regions per
hemisphere (Fig. 1).
2.5. Statistical analyses
Statistical analyses were performed using SPSS software v. 21 (IBM,
Chicago, IL) and SAS/STAT software (SAS Institute Inc., Cary, NC, USA).
We compared demographic characteristics between groups using
independent samples t-tests for continuous variables and chi-square
test for categorical variables. To ensure that there were no cross-
scanner differences, for all neuroanatomic measurements, we
conducted a univariate analysis of covariance (ANCOVA) for eacheveloping controls, in lateral (left) and medial (right) cortical structures.
Table 1
Demographic and clinical characteristics of study participants.
22q11DS
participants
(n=31)
Healthy
comparison
participants
(n=34)
Age (years± SD) 16.4 (4.2) 15.7 (3.8) p= .47
Participant education (years± SD) 8.5 (3.7) 9.2 (3.6) p= .49
Parental education (years± SD) 16.2 (2.9) 15.4 (2.9) p= .27
Gender (n, % female) 16 (52%) 14 (42%) p= .39
Race (Asian/African American/
Caucasian/multiple)
0/1/27/3 3/4/22/5 p= .13
Ethnicity (n, % Latino) 7 (23%) 13 (38%) p= .17
Psychotic disorder diagnosis (n, %) 3 (10%) NA
SIPS positive symptoms (mean± SD) 7.1 (6.9) 1.1 (1.6) p b .001
SIPS negative symptoms 9.2 (6.4) 1.1 (1.7) p b .001
SIPS disorganized symptoms 4.7 (3.7) 0.7 (1.0) p b .001
SIPS general symptoms 4.9 (5.0) 1.1 (1.4) p= .001
Psychotic symptoms
(positive+negative symptoms on SIPS)
16.3 (11.9) 2.2 (3.0) p b .001
Psychotropic medication (n, none/
antipsychotics/antidepressants)
22/3/6 NA
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between-group factor and group as a covariate.
All neuroanatomicmeasureswere examined for normality using the
Kolmogorov–Smirnov and Shapiro–Wilk tests and transformed
appropriately if they violated assumptions of normality. To compare
global measures of total intracranial volume, total cortical volume, SA,
and CT between 22q11DS participants and controls, we conducted a
univariate ANCOVA with each neuroanatomic measure as the
dependent variable, diagnosis as the between-group factor, and age,
gender, and scanner location as covariates. To compare brain volume,
CT, and SA in 22q11DS vs. controls, we conducted an ANCOVA for
each identiﬁed region in each hemisphere, with diagnosis (22q11DS
vs. control) as the between subject factor and total intracranial brain
volume/SA, sex, scanner site, and age as the covariates. To ensure that
outliers were not driving any of our signiﬁcant differences, these
analyses were also conducted with outliers (those with values N3
standard deviations away from the mean value) removed.
To address whether the relationship between age and
neuroanatomic measures differed between groups, we ﬁrst visually
examined the scatter plots. In plots that visually indicated age ∗ group
interactions, we then added age∗group interaction terms to the original
ANCOVA models for each brain region. This resulted in a total of 14
analyses. We examined volume in the left paracentral cortex and right
precuneus, CT in the right frontal pole, lateral occipital and lingual
cortices and left pericalcarine region, and in bilateral middle frontal,
precuneus, postcentral and fusiform cortices. If signiﬁcant group ∗ age
interactions were detected, Pearson correlations between the ROI and
age were calculated for each group (22q11DS and controls) separately.
Then, to directly compare the strength of correlations between the two
groups, a Fisher r-to-z transformation was conducted.
For statistical analyses corresponding to the third aim of our study
(i.e., to determine whether the brain regions investigated above are
associated with variability in positive symptoms in 22q11DS patients),
we examined the relationship between CT and SA and SIPS positive
symptom scores in 22q11DS. Because cortical volume is derived from
these two indices, we did not additionally examine volume in relation
to positive symptoms. Residuals were calculated from each variable,
after regressing out the effects of age and sex. Then, Pearson correlations
(corresponding to age- and sex-adjusted partial correlations) were
conducted between each brain region with residualized positive
symptoms.
False discovery rate (FDR) q-valueswere used to correct formultiple
comparisons (300 comparisons in total), and were estimated using
SAS/STAT software (SAS Institute Inc., Cary, NC, USA), with a threshold
of q b .05 considered statistically signiﬁcant. We also note statistical
trends in the results (q-valuesN .05 and b .20), as potentially interesting
for investigation in future, larger-scale studies.
3. Results
As shown in Table 1, 22q11DS patient and control groups were
matched on all demographic factors (all p-values≥ 0.10). There were
no between-scanner differences in volume, CT, or SA that survived
multiple comparison correction (see Supplemental materials, Table 1).
Nevertheless, because some statistical trends emerged for speciﬁc
structures we covaried for scanner site in all subsequent analyses.
Statistics for global measures of intracranial volume, whole brain
cortical volume, CT, and SA are reported in the Supplementarymaterials,
Table 2. In comparison to controls, 22q11DS participants showed
signiﬁcantly decreased total intracranial volume, whole brain volume,
and total SA, but increased overall mean CT.
3.1. Volumetric results
Results of group comparisons for brain volumes are presented in
Table 2. After correcting for multiple comparisons, individuals with22q11DS had signiﬁcantly smaller volumes than controls in the anterior
cingulate, fusiform gyrus, cuneus, precuneus, superior parietal and
inferior temporal cortices bilaterally, and in the right precentral and
middle frontal cortices. In contrast, in bilateral regions of the insula
and the right medial orbitofrontal cortex, individuals with 22q11DS
had greater volumes than controls. The greatest effect sizes were
observed for the cuneus (left: partial η2= .40; right: partial η2= .25),
right insula (partial η2= .27) and left inferior temporal cortex (partial
η2=.28).
3.2. Surface area results
Results for the group comparisons of brain SA are also presented in
Table 2. F-value overlays are presented in Fig. 2. In comparison to
controls, 22q11DS participants had signiﬁcantly reduced SA in
bilateral anterior cingulate, cuneus, precuneus, fusiform gyrus, lingual,
pericalcarine, superior parietal, middle frontal, and inferior temporal
cortices, as well as in right banks of the superior temporal sulcus, right
superior temporal, right postcentral, left temporal pole and left middle
temporal regions, in comparison to controls. The greatest effect sizes
were observed for the cuneus (left: partial η2 = .59; right: partial
η2= .40), right middle frontal (partial η2= .41), left inferior temporal
(partial η2=.39), and right superior parietal regions (partial η2=.32).
3.3. Cortical thickness results
A different pattern of results emerged when examining group
differences in CT (see Table 2, Fig. 2). In comparison to controls,
individuals with 22q11DS had increased CT in bilateral regions of the
insula, paracentral, middle frontal, and medial orbitofrontal cortices, as
well as right middle temporal, lingual, and supramarginal regions, and
the left frontal pole, inferior frontal, pericalcarine cortices. The greatest
effect sizes were observed for the middle frontal cortices (left partial
η2=.24; right: partial η2=.31),medial orbitofrontal regions (left partial
η2=.19; right: partial η2=.24), and insula (left partial η2=.24; right:
partial η2 = .31). In contrast, 22q11DS participants had decreased
CT in the left parahippocampal region, relative to controls (partial
η2=.14).
3.4. Age ∗ group interactions
For the fourteenmeasurements inwhich visual inspection suggested
an age ∗ group interaction, interaction terms were added to the
original ANCOVAs examining group differences. Speciﬁcally, signiﬁcant
age ∗ group interactions were observed for CT in multiple regions (see
Table 2
Group comparisons for neuroanatomic measures: 22q11DS participants versus typically developing controls. Bold values indicate a statistically signiﬁcant difference between
neuroanatomic measures in 22q11DS versus controls.
Volume Cortical thickness Surface area
Region of interest Hemisphere F FDR q-value ↑ or ↓ in 22q11DS F FDR q-value ↑ or ↓ in 22q11DS F FDR q-value ↑ or ↓ in 22q11DS
Inferior frontal L 0.19 0.87 18.68 0.0008 ↑ 0.21 0.86
R 0.00 0.98 6.88a 0.06 ↑ 0.71 0.70
Middle frontal L 4.71a 0.13 ↓ 18.79 0.0008 ↑ 15.24 0.003 ↓
R 13.96 0.003 ↓ 25.94 0.0002 ↑ 41.09 0.00002 ↓
Superior frontal L 1.07 0.62 1.98 0.41 4.01a 0.16 ↓
R 0.38 0.79 4.33a 0.15 ↑ 0.05 0.93
Medial orbitofrontal L 6.77a 0.06 ↑ 14.21 0.004 ↑ 0.01 0.98
R 14.68 0.003 ↑ 18.70 0.0008 ↑ 0.63 0.71
Lateral orbitofrontal L 2.52 0.32 5.19a 0.09 ↑ 0.03 0.94
R 0.87 0.68 4.30a 0.15 ↑ 0.27 0.84
Frontal pole L 0.624 0.71 16.18 0.002 ↑ 0.341 0.75
R 1.74 0.46 0.04 0.94 1.38 0.46
Insula L 13.01 0.005 ↑ 19.86 0.0007 ↑ 4.02a 0.16 ↑
R 22.20 0.0004 ↑ 19.48 0.0008 ↑ 3.24 0.23
Anterior cingulate L 12.43 0.007 ↓ 0.83 0.68 16.80 0.002 ↓
R 9.27 0.02 ↓ 0.42 0.78 16.59 0.002 ↓
Isthmus cingulate L 0.00 0.97 3.16 0.23 1.37 0.53
R 0.54 0.69 0.32 0.81 0.816 0.68
Posterior cingulate L 3.15 0.23 0.03 0.94 5.26a 0.11 ↓
R 0.66 0.71 0.37 0.79 0.92 0.67
Precentral L 0.75 0.69 2.10 0.38 0.378 0.79
R 7.82 0.04 ↓ 5.48a 0.10 ↑ 1.65 0.48
Paracentral L 0.14 0.90 11.33 0.007 ↑ 6.13a 0.07 ↓
R 0.02 0.96 8.96 0.024 ↑ 1.46 0.52
Postcentral L 0.04 0.94 6.47a 0.07 ↑ 6.91a 0.06 ↓
R 2.75 0.29 1.82 0.44 10.8 0.01 ↓
Superior parietal L 18.68 0.0008 ↓ 0.19 0.87 22.6 0.00034 ↓
R 15.65 0.002 ↓ 1.78 0.45 28.07 0.00009 ↓
Supramarginal L 0.801 0.68 7.17 0.05 ↑ 0.1 0.91
R 0.628 0.71 11.29 0.007 ↑ 0.016 0.96
Inferior parietal L 0.11 0.91 2.85 0.27 0.89 0.68
R 0.07 0.92 4.09a 0.16 ↑ 1.53 0.50
Lateral occipital L 1.9 0.42 0.37 0.79 3.77a 0.18 ↓
R 1.53 0.50 0.47 0.78 4.40a 0.15 ↓
Precuneus L 8.838 0.02 ↓ 4.01a 0.16 ↑ 28.87 0.00005 ↓
R 4.02a 0.16 ↓ 2.89 0.27 16.66 0.002 ↓
Cuneus L 39.11 0.00005 ↓ 3.61a 0.19 ↑ 83.39 0.000001 ↓
R 20.09 0.0007 ↓ 0.433 0.78 39.93 0.00001 ↓
Pericalcarine L 2.28 0.36 11.53 0.007 ↑ 16.04 0.002 ↓
R 3.65a 0.19 ↓ 4.93a 0.12 ↑ 13.83 0.004 ↓
Lingual L 6.51a 0.06 ↓ 7.08a 0.05 ↑ 20.65 0.0006 ↓
R 5.69a 0.09 ↓ 9.58 0.02 ↑ 21.26 0.0005 ↓
Fusiform L 9.53 0.02 ↓ 0.11 0.91 12.91 0.007 ↓
R 8.45 0.03 ↓ 5.63a 0.09 ↑ 24.55 0.0002 ↓
Inferior temporal L 23.07 0.0003 ↓ 0.17 0.87 38.19 0.00002 ↓
R 9.56 0.02 ↓ 0.80 0.68 15.59 0.002 ↓
Middle temporal L 0.36 0.79 2.36 0.35 9.59 0.02 ↓
R 0.06 0.92 7.66 0.04 ↑ 4.00a 0.16 ↓
Superior temporal L 2.14 0.38 4.85a 0.13 ↓ 0.01 0.96
R 5.30a 0.11 ↓ 0.00 0.98 6.64a 0.06 ↓
Banks of superior temporal sulcus L 0.79 0.68 0.73 0.69 1.61 0.48
R 6.38a 0.07 ↓ 0.44 0.78 11.51 0.007 ↓
Transverse temporal pole L 0.461 0.78 0.33 0.81 1.55 0.50
R 4.7a 0.13 ↓ 0.98 0.65 4.33a 0.15 ↓
Temporal pole L 1.41 0.53 3.31 0.22 18.96 0.0008 ↓
R 3.39a 0.21 ↓ 1.04 0.63 6.88a 0.06 ↓
Entorhinal L 0.07 0.92 0.115 0.91 3.545 0.31
R 0.03 0.94 2.75 0.29 0.082 0.92
Parahippocampal L 4.10a 0.16 ↓ 9.45 0.02 ↓ 0.00 0.98
R 0.23 0.85 0.18 0.87 0.61 0.71
a Indicates measures that showed statistical trends in the results (q-values N .05 and b .20).
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.08), fusiform gyrus (F(1,59)=5.77, p=.02, partial η2=.09), precuneus
(F(1,59) = 5.61, p= .02, partial η2= .09), as well as the right lingual
(F(1,59) = 10.21, p= .002, partial η2 = .15) and postcentral cortices
(F(1,59) = 7.11, p = .01, partial η2 = .11). Age ∗ group interaction
terms did not reach statistical signiﬁcance for the following regions:
volumetric measures of left paracentral cortex and right precuneus, CT
in the right frontal pole, fusiform gyrus, precuneus, and lateral occipitalcortex, left postcentral cortex, and in bilateral middle frontal regions.
For all regions that showed a signiﬁcant age∗group interaction, controls
showed a highly signiﬁcant pattern of decreasing CT with increasing
age, which was not observed in 22q11DS participants. Fisher's test for
the equivalence of correlations showed that, in four of these regions
(left pericalcarine and fusiform regions, right lingual and postcentral
cortices), the strength of the correlation was signiﬁcantly greater in
controls relative to 22qDS participants (Supplementary Table 3).
Fig. 2. Increases in cortical thickness (A) and decreases in surface area (B) in 22q11DS vs. typically developing controls. Shows an overlay of effect size (partial η2, values indicated by the
color bar) on each FreeSurfer region of interest between those with 22q11DS and typically developing controls. Warm colors indicate a larger effect size, or a greater difference between
22q11DS vs. controls.
410 M. Jalbrzikowski et al. / NeuroImage: Clinical 3 (2013) 405–4153.5. Relationship between MRI indices and positive symptoms in 22q11.2
deletion syndrome
Correlations were conducted for each of the CT and SA MRI indices.
After FDR correction was applied, there was a signiﬁcant positive
correlation between rightmedial orbitofrontal CT andpositive symptoms
in 22q11DS participants (r = .46, q = .04). Increased CT in the right
medial orbitofrontal cortex was associated with increased positive
symptoms in 22q11DS (Fig. 4). Additional trend-level associations
observed in this analysis are reported in Supplementary Table 4. Of
note, trend-level associationswere detected between positive symptoms
and SA measures in multiple temporal regions: the left (r=− .38, q=
.14) and right middle temporal (r = − .34, q = .19), right inferior
temporal (r = − .36, q = .15), and temporal pole regions (r =− .34,
q = .19). In all four regions, as SA decreased, positive symptoms
increased in severity in those with 22q11DS.4. Discussion
To our knowledge, this is the ﬁrst study to examine regional
differences in brain structures on the basis of their separable components
(volume, cortical thickness, and surface area) in 22q11.2 microdeletion
syndrome (22q11DS), a recurrent genetic mutation associated with
high rates of psychosis. We also investigated age-associated trajectories
in these structures in 22q11DS participants vs. typically developing
controls, and explored relationships between structural variation in
these brain regions and dimensional measures of positive symptom
severity. These analyses yielded several novel ﬁndings: 1) measures of
volume, CT, and SA indicate distinct patterns of group differences,
involving reduced cortical volume and SA in occipito-parietal, temporal
and anterior cingulate cortices, whereas increased CT was observed in
multiple frontal regions and the insula; 2) multiple regions, including
the fusiform gyrus, showed cortical thinning with increasing age in
typically developing controls, but this pattern of age-associated cortical
thinning was not present in 22q11DS; and 3) increased CT in the right
medial orbitofrontal cortex was associated with greater severity of
positive symptoms in 22q11DS.Fig. 3. Distinct patterns of age-associated changes in cortical thickness in 22q11DS patients re
cortex, (C) left precuneus, (D) right lingual cortex, and (E) right postcentral cortex. In each reg
not observed in 22q11DS patients. F-statistic is reported for each signiﬁcant interaction.4.1. Group differences in cortical volume, thickness, and surface area
Analysis of multiple neuroanatomic indices (e.g., volume, CT, and
SA) revealed a complex and intriguing pattern of results. Consistent
with previous studies, we found volumetric reductions in occipito-
parietal (Bearden et al., 2007; Gothelf et al., 2007b; Kates et al., 2001),
temporal (Chow et al., 2011; van Amelsvoort et al., 2004) and anterior
cingulate cortices (Dufour et al., 2008; Shashi et al., 2010) in 22q11DS;
ours is the ﬁrst study to show that these reductions are driven by
decreased SA. Our ﬁndings of increased bilateral insular volumes
replicate ﬁndings from two separate laboratories (Campbell et al.,
2006; Simon et al., 2005). Here, we extend upon these ﬁndings by
showing that increased CT, not changes in SA, drives increased volumes
in these regions. Finally, while our ﬁndings are in linewith prior studies
that conclude that cortical volumes ofmost frontal regions are relatively
“intact” in children and adolescents with 22q11DS (Eliez et al., 2000;
Kates et al., 2004; Simon et al., 2005), we additionally showed that CT
in the bilateral medial orbitofrontal, middle and inferior frontal cortices
was signiﬁcantly increased in those with 22q11DS in comparison to
typically developing controls. While the volumetric increase we
observed in medial orbitofrontal cortex in 22q11DS was in the opposite
direction of the one prior study, to our knowledge, that has reported on
orbitofrontal cortical volumes in 22q11DS (Kates et al., 2011b), no other
studies have examined indices of CT and SA together in 22q11DS. Our
results replicate previous ﬁndings using a different methodology in
youth ages 9–15years old, which also foundmultiple areas of increased
CT in 22q11DS relative to healthy controls, primarily in frontal brain
regions (Schaer et al., 2009). Interestingly, though CT in the middle
frontal region was increased, the volume and SA of this region were
both decreased in 22q11DS. It has been shown that SA is more strongly
related to volume than is CT (Winkler et al., 2010), providing a possible
explanation for ﬁndings of increased CT and decreased volume in the
same brain region. Again, this ﬁnding highlights the importance of
examining indices of CT and SA separately.
By examining separate components of volume (i.e., SA and CT) we
may begin to better understand the underlying neural dysfunction in
22q11DS, given the distinct neurodevelopmental origins of these two
indices (Pontious et al., 2008). Speciﬁcally, converging evidencelative to typically developing controls in the (A) left fusiform gyrus, (B) left pericalcarine
ion, controls show the expected pattern of cortical thinning with increasing age, which is
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Fig. 4. Relationship between increased cortical thickness in the right medial orbitofrontal cortex and positive symptom severity in 22q11DS. Medial orbitofrontal cortical thickness and
positive symptoms are residuals, with effects of age and sex regressed out.
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progenitors, which consist of neuroepithelial cells and radial glial cells
(Pontious et al., 2008). Therefore the decreased SA seen in the anterior
cingulate and inferior temporal regions in 22q11DSmay reﬂect reduced
production of radial unit progenitors in these areas of the cortex.
Meanwhile, CT is believed to be determined by intermediate progenitor
cells, which produce only neurons and are considered to be transient
cells whose job is to amplify cells within the developing cortex
(Pontious et al., 2008). Thus, increased cortical thickness, which was
seen in multiple frontal regions, may have occurred as a result of over-
proliferation of intermediate progenitor cells during corticogenesis.
Furthermore, previous studies of 22q11.2 deletion mouse models
suggest that reduced dosage of genes within the 1.5-megabase 22q11
minimal critical deleted region results in a disruption of basal
progenitor proliferation in the cortex and abnormal migration of
interneurons in themedial cortex (Meechan et al., 2009). These ﬁndings
suggest that disrupted corticogenesis due to basal progenitor defects
may play a role in circuit vulnerability and behavioral alterations in
the 22q11.2 mouse model (Meechan et al., 2012), which may in turn
be relevant to the observed CT and SA alterations in our sample. The
ﬁndings in the mouse model were restricted to the medial wall and
thus may not fully explain the changes in SA and CT observed in our
human22q11DS sample.Nevertheless,Meechan et al.'s intriguingﬁnding
of abnormal interneuron migration due to reduced 22q11.2 gene
dosage, particularly the Cxcr4 gene, suggests a molecular mechanism
for disruptedneurodevelopment in 22q11DS, a possibilitywhich should
be investigated further in both animalmodels and human post-mortem
studies. It should also be noted that our ﬁndings are constrained by the
manner in which FreeSurfer calculates these MRI indices, limiting our
neurobiological interpretations. Furthermore, alterations in cortical
volume may be linked to other cellular processes, such as decreased
dendritic spine density (Glantz and Lewis, 2000), changes in interneurons
(Benes et al., 1991), or reduction in neuronal cell size (Pennington et al.,
2008). Finally, given that structural MRI is an indirect measure
of neuronal processes, our conclusions regarding the underlying
neuropathology of the CT and SA differences observed in 22q11DS
are necessarily speculative. Nevertheless, it is notable that a recent
high-resolution MRI study of the 22q11.2 deletion mouse model
(Df(16)A+/−) found that the brain abnormalities in these mice
recapitulate some of the most common neuroanatomical ﬁndings in
human patients, particularly increased striatal volume and – consistent
with our ﬁndings – relative volumetric increases in the frontal lobe in
Df(16)A+/− mice compared with wild-type littermates (Ellegood
et al., 2013). These similarities highlight the face validity of the
22q11.2 mouse model as a means of advancing our understanding of
the critical pathogenic mechanisms involved in abnormal brain
development in human 22q11.2 deletion carriers.
Human neuroimaging studies have also shown that SA and CT have
separate genetic origins (Panizzon et al., 2009; Winkler et al., 2010).
Notably, the genetic dissociation of CT and SA is also supported byanimal models, which show that mutation of speciﬁc genes involved
in neurodevelopment (PAX6, LRP6, and NGN1/2) affects the number of
progenitor cells, resulting in concomitant increases in CT but not SA, a
ﬁnding which was validated in humans (Baala et al., 2007; Glaser
et al., 1994; Joyner et al., 2009). In contrast, variation inMECP2, a gene
known to be involved in brain structural development, was associated
with variation in SA but not CT within speciﬁc cortical regions
(e.g., cuneus, fusiform, inferior frontal gyrus; Joyner et al., 2009). Thus,
the differential patterns of brain disruption that we observed
(e.g., increased CT in frontal and insular cortices, but decreased SA in
the anterior cingulate and inferior temporal regions) suggest that
these alterations may also reﬂect disruptions of different genetic
mechanisms in 22q11DS. In addition, evidence suggests that particular
genes within the 22q11.2 region (e.g., RANBP1, CADC45l, Cxcr4) may
contribute to the observed alterations in cortical development in the
mouse (Meechan et al., 2009, 2012). Future studies examining the
relationship between these genes and cortical development, in human
and animal models, are necessary to expand upon and validate these
ﬁndings.
4.2. Relationships between MRI indices and positive symptoms in 22q11.2
deletion syndrome
Importantly, we found that increased CT in the right medial
orbitofrontal cortex, a brain region critically involved in social cognition
(Amodio and Frith, 2006), was associated with more severe positive
symptoms in 22q11DS. Though increased orbitofrontal thickness is
not typically reported in individuals with idiopathic schizophrenia,
there is substantial heterogeneity in ﬁndings, with some studies ﬁnding
increased orbitofrontal cortical volume in ﬁrst-episode schizophrenia
(Szeszko et al., 1999), while others have found reduced volumes
(Convit et al., 2001) (Gur et al., 2000) or no signiﬁcant differences
(Sapara et al., 2007). These disparate ﬁndings may be due to the
heterogeneous nature of schizophrenia, thus highlighting the value of
investigatingwell characterized, homogenous subtypes of schizophrenia.
However, our ﬁndings provide preliminary evidence that neuroanatomic
regions that are particularly relevant for socially oriented interactions
(Amodio and Frith, 2006) also play a role in the development of
psychosis in 22q11DS. Our recent behavioral studies show that social
cognition performance is a better predictor of positive symptoms in
22q11DS than non-social cognitive measures, supporting this notion
(Jalbrzikowski et al., 2012).
We also found several trend-level relationships, including reduced
SA in multiple temporal regions associated with greater severity of
positive symptoms in 22q11DS. These ﬁndings are consistent with
prior cross-sectional studies of both adults (Chow et al., 2002, 2011)
and children with 22q11DS (Bearden et al., 2004), and additionally
suggest that SA reductions may be driving the previously observed
associations between temporal lobe volume and symptom severity.
These ﬁndings also support existing longitudinal studies of both clinical
413M. Jalbrzikowski et al. / NeuroImage: Clinical 3 (2013) 405–415high-risk youth and adolescents with 22q11DS, which have shown that
volumetric decreases in temporal regions are associated with the
development of more severe prodromal or psychotic symptomatology
(Kates et al., 2011a; Takahashi et al., 2009). Taken together, these
ﬁndings provide corroborating evidence that aberrant temporal lobe
morphology may play a critical role in the development of psychosis
in both 22q11DS and the broader population.
The additional trend-level associations we observed between
reduced SA in occipital regions (e.g., pericalcarine, lingual) and
increased positive symptoms have, to our knowledge, not been
reported in previous studies; however, this may be due to the fact
that most studies to date have not taken an unbiased approach to
examine brain–behavior relationships across all cortical regions.
4.3. Age-associated changes in cortical thickness
We also found several age ∗ group interactions in occipital
(i.e., pericalcarine, fusiform, and lingual regions) and parietal regions
(i.e., precuneus, postcentral regions), in which typically developing
controls showed highly signiﬁcant cortical thinning with increasing
age, as found in previous studies of typically developing adolescents
and young adults (Tamnes et al., 2010). In contrast, this pattern was
not observed in 22q11DS individuals. These ﬁndings suggest that
adolescent cortical maturation in parieto-occipital regions may be
disrupted in 22q11DS. These ﬁndings, however, need to be conﬁrmed
with prospective longitudinal studies and larger sample sizes.
Furthermore, two of these regions, the fusiform gyrus and
precuneus, are known to be important for socially relevant processes
(Cavanna and Trimble, 2006; Schultz et al., 2003). Thus, disruption of
cortical maturation in these areas may be related to social cognitive
impairments observed in youth with 22q11DS (Campbell et al., 2011;
Ho et al., 2012). Thus, in the future, it will be important to examine
whether structural and functional variations in socially-relevant brain
regions are related to social cognitive development in 22q11DS.
4.4. Study limitations
Several limitations to this study should be noted. First, given
the cross-sectional design we were unable to investigate baseline
neuroanatomic measures, or change in these variables over time, as
predictors of subsequent psychotic symptom development. Given that
recent ﬁndings suggest that regional neuroanatomic changes over
time predict prodromal symptoms, assessed by the SIPS (Kates et al.,
2011a), it is critical that future studies incorporate a longitudinal
approach. Additionally, it will be important to investigate whether
our cross-sectional ﬁnding suggesting a disrupted trajectory of CT in
the middle frontal region in 22q11DS is replicated in a within-subject,
longitudinal design. Also, regarding the association of our neuroanatomic
measures with positive symptoms, the majority of the 22q11DS
participants in our sample were not fully psychotic; only three
22q11DS participants had a diagnosis of a psychotic disorder, and thus
we used dimensional measures of positive symptoms as our dependent
variable. Nevertheless, given that psychotic symptoms are continuously
distributed in the general population (Ahmed et al., 2011), utilizing a
dimensional approach may be more powerful than investigating
psychotic symptoms as a categorical variable.
4.5. Implications for idiopathic schizophrenia
Given that 22q11DS is one of the greatest known risk factors for
psychosis, it is important to examine how these results relate to the
existing literature on idiopathic schizophrenia. At ﬁrst glance, the
results may seem counter-intuitive, given that many of our results were
driven by increased CT, while exaggerated cortical thinning in multiple
brain regions has been associated with conversion to psychosis (Sun
et al., 2009; Takahashi et al., 2009), alongwith poorer neuropsychologicalfunctioning and more severe clinical symptomatology in patients with
established schizophrenia (Cobia et al., 2012). While the direction of
effects observed in frontal regions in our 22q11DS sample may not
have been predicted based on existing literature on idiopathic
psychosis, it may be that there are multiple pathways of disruption in
particular brain regions relevant for the development of psychosis,
resulting in similar downstream phenotypic effects. While many
researchers speculate that increased cortical thinning in idiopathic
schizophrenia is suggestive of an overly aggressive synaptic pruning
process (Hoffman and McGlashan, 1997; Keshavan et al., 1994), it is
possible that the increased CT observed in primarily frontal regions in
22q11DSmaybedue to neuronal over-proliferation in these brain regions,
resulting in a similar behavioral phenotype (e.g., positive symptoms). Use
of an unbiased, whole-brain analytic approach revealed additional
neuroanatomic differences in 22q11DS individuals that are unique to
this population and not characteristic of idiopathic schizophrenia (i.e.,
occipito-parietal regions, Bearden et al., 2007; Gothelf et al., 2007b;
Kates et al., 2001). Therefore, the overall neuroanatomic proﬁle of
22q11DS individuals may represent an independent manifestation of
aberrant brain development. However, given the clear and consistent
association of the 22q11.2 deletion with schizophrenia risk (Debbane
et al., 2006; Gothelf et al., 2007a; Schneider et al., 2013), future
investigations that focus on cortical regions directly related to psychotic
symptomatology in 22q11DS (e.g., medial frontal regions) may be
particularly informative regarding pathophysiologicmechanisms relevant
to psychosis risk and protective factors in this population.
4.6. Conclusions
Findings from the current study suggest that neuroanatomic
abnormalities in brain regions disproportionately affected in idiopathic
schizophreniamaybe driven by distinct neurodevelopmental processes;
as such, different mechanismsmay underlie disruptions associated with
psychosis risk, both in the context of 22q11.2 microdeletion syndrome
and the general population. Future experiments in animal models of
the 22q11.2 deletion, in which speciﬁc genes in the region are rescued,
may provide direct links between mechanisms of disruption in cortical
development and psychosis pathogenesis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2013.09.013.
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